Industriebank Liof NV

Embrosa specializes in delivering marketing content from the brand's HQ to local retailers across the globe.

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and fuels.

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

VACIS is the leading tissue engineering company for body-own blood vessels.VACIS develops in situ tissue engineered blood vessels providing novel therapeutic options for vascular surgery. Prosthetic vascular graft failure is a frequent complication in vascular surgery with substantial morbidity and health care costs. VACIS provides patients autologous graft vessels, with sustained patency and fewer complications requiring less corrective interventions.

Paztir automates vehicle and box locks, tracks, and manages access, helping you save up to 30 minutes daily per vehicle, keeping your assets safe, and providing you with performance insights.

Grassa BV richt zich op het verwaarden van plantaardige stromen door middel van bioraffinage. Grassa haalt veel méér uit gras en gewas: hoogwaardige, eiwitrijke veevoeding én een goede bestemming voor de reststromen. Met een mobiele raffinagemachine verwerkt Grassa bijvoorbeeld vers gras vanaf de weide, reststromen uit de tuinbouw, woekerende waterplanten uit de rivieren of natuurgras uit natuurgebieden. Na raffinage komen vier producten vrij: vezels, eiwit, fosfaat en ‘wei’ (sap).

Phenospex provides digital solutions that capture crop data and convert it into actionable information, amplifying the effect of countless individuals and speeding up the transition to sustainable agriculture. They offer clever digital phenotyping solutions that include sensors, software, and full process automation. Their goal is to automate the process, turn data into action, and enable their clients to produce innovative agrochemicals and crops more quickly than ever before.

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec. CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases.

Innosolids is a young dynamic company that focuses on marketing and development of color solutions for the plastics industry in Europe. Our technical staff has earned its mark in the R & D and production of color solutions at well-known international companies. We are located near to the famous Technology and Cheminal Center “Brightland Campus” on the Chemelot / DSM area in Geleen. This gives us technical advantages regarding the latest technological and chemical inventions. We have accumulated invaluable experience in the field of color development.

QCP provides brand owners and plastics convertors with polymers of high and consistent quality based on used plastics.

Ekompany is a Dutch producer of coated mineral fertilisers (CRF) with sales operations in Western Europe and Far East. Their team of professionals possesses the latest knowledge across the chemical, agricultural and horticultural fields and have decades of experience in designing, producing and supplying specialty fertilisers supported by the right advice. Established in 2010, their unique production facility in Born was opened for production in September 2013. Ekompany has developed a patented coating process that is clean, safe, continuous and more energy efficient than existing ones. This way they can produce intelligent Controlled Release Fertilisers that are both technologically advanced and economical for wider use in agriculture and horticulture. Learn more about their Ekote portfolio which has proven its benefits in more than 200 field trials internationally.

Phenospex provides digital solutions that capture crop data and convert it into actionable information, amplifying the effect of countless individuals and speeding up the transition to sustainable agriculture. They offer clever digital phenotyping solutions that include sensors, software, and full process automation. Their goal is to automate the process, turn data into action, and enable their clients to produce innovative agrochemicals and crops more quickly than ever before.

MagnaMedics engineers and produces magnetic nano- and microparticles that are used in medical devices, drug delivery tools and diagnostic kits. Diagnostic kits are used for determination of biomarkers in body fluids; the company focuses on proteomics and more specifically on high-quantity isolation of proteins as well as on research customers active in high-throughput screening of biomarkers.

FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, Health Innovations, Limburg Ventures and NV Industriebank LIOF. The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.

TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.

Fortimedix is a global leader in the field of endovascular stents. With full in-house stent development and manufacturing capabilities, they have been a trusted partner for over 15 years. As a leader in stent technology, they invest heavily in research & development which fosters innovation, enables continuous improvement, and fulfils their dedication to operational excellence. At Fortimedix everything they do is inspired by their Mission and Vision. It is of great importance to us that their customers, employees and stakeholders know what they stand for and where they are going.